Literature DB >> 25464861

SMAD4 and its role in pancreatic cancer.

Xiang Xia1, Weidong Wu, Chen Huang, Gang Cen, Tao Jiang, Jun Cao, Kejian Huang, Zhengjun Qiu.   

Abstract

Transforming growth factor-β (TGF-β) regulates cell functions and has key roles in pancreatic cancer development. SMAD4, as one of the Smads family of signal transducer from TGF-β, mediates pancreatic cell proliferation and apoptosis and is specifically inactivated in half of advanced pancreatic cancers. In recent years, many advances concerning SMAD4 had tried to unravel the complex signaling mechanisms of TGF-β and its dual role of tumor-suppressive and tumor-promoting efforts in pancreatic cancer initiation and progression through SMAD4-dependent TGF-β signaling and SMAD4-independent TGF-β signaling pathways. Meanwhile, its potential prognostic value based on immunohistochemical expression in surgical sample was variably reported by several studies and short of a systematic analysis. This review aimed to discuss the structure, functions, and regulation of this principal protein and its effects in determining the progression and prognosis of pancreatic cancer.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25464861     DOI: 10.1007/s13277-014-2883-z

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  94 in total

1.  Loss of Dpc4 expression in colonic adenocarcinomas correlates with the presence of metastatic disease.

Authors:  A Maitra; K Molberg; J Albores-Saavedra; G Lindberg
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

2.  Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas : a new marker of DPC4 inactivation.

Authors:  R E Wilentz; G H Su; J L Dai; A B Sparks; P Argani; T A Sohn; C J Yeo; S E Kern; R H Hruban
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

3.  Transforming growth factor-beta induces nuclear import of Smad3 in an importin-beta1 and Ran-dependent manner.

Authors:  A Kurisaki; S Kose; Y Yoneda; C H Heldin; A Moustakas
Journal:  Mol Biol Cell       Date:  2001-04       Impact factor: 4.138

4.  STAT3-targeting RNA interference inhibits pancreatic cancer angiogenesis in vitro and in vivo.

Authors:  Chen Huang; Tao Jiang; Lin Zhu; Jun Liu; Jun Cao; Ke-Jian Huang; Zheng-Jun Qiu
Journal:  Int J Oncol       Date:  2011-04-08       Impact factor: 5.650

Review 5.  The pathology of ductal-type pancreatic carcinomas and pancreatic intraepithelial neoplasia: insights for clinicians.

Authors:  Günter Klöppel; Jutta Lüttges
Journal:  Curr Gastroenterol Rep       Date:  2004-04

6.  TGFbeta prevents proteasomal degradation of the cyclin-dependent kinase inhibitor p27kip1 for cell cycle arrest.

Authors:  Jon Lecanda; Vidya Ganapathy; Christine D'Aquino-Ardalan; Brad Evans; Caprice Cadacio; Aidee Ayala; Leslie I Gold
Journal:  Cell Cycle       Date:  2009-03-16       Impact factor: 4.534

7.  Missense mutations of MADH4: characterization of the mutational hot spot and functional consequences in human tumors.

Authors:  Christine A Iacobuzio-Donahue; Jason Song; Giovanni Parmiagiani; Charles J Yeo; Ralph H Hruban; Scott E Kern
Journal:  Clin Cancer Res       Date:  2004-03-01       Impact factor: 12.531

8.  Orthotopic transplantation models of pancreatic adenocarcinoma derived from cell lines and primary tumors and displaying varying metastatic activity.

Authors:  Panayiotis Loukopoulos; Kengo Kanetaka; Masaaki Takamura; Tatsuhiro Shibata; Michiie Sakamoto; Setsuo Hirohashi
Journal:  Pancreas       Date:  2004-10       Impact factor: 3.327

9.  Nucleocytoplasmic shuttling of Smads 2, 3, and 4 permits sensing of TGF-beta receptor activity.

Authors:  Gareth J Inman; Francisco J Nicolás; Caroline S Hill
Journal:  Mol Cell       Date:  2002-08       Impact factor: 17.970

10.  Cell size and invasion in TGF-beta-induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway.

Authors:  Samy Lamouille; Rik Derynck
Journal:  J Cell Biol       Date:  2007-07-23       Impact factor: 10.539

View more
  37 in total

Review 1.  The Enigma of Rapamycin Dosage.

Authors:  Suman Mukhopadhyay; Maria A Frias; Amrita Chatterjee; Paige Yellen; David A Foster
Journal:  Mol Cancer Ther       Date:  2016-02-25       Impact factor: 6.261

2.  Chloride intracellular channel 1 (CLIC1) is activated and functions as an oncogene in pancreatic cancer.

Authors:  Jianhua Lu; Qian Dong; Bingtai Zhang; Xuefeng Wang; Bin Ye; Fei Zhang; Xiaoling Song; Guofeng Gao; Jiasheng Mu; Zheng Wang; Fei Ma; Jun Gu
Journal:  Med Oncol       Date:  2015-04-26       Impact factor: 3.064

3.  Role of RHOT1 on migration and proliferation of pancreatic cancer.

Authors:  Qingqing Li; Lei Yao; Youzhen Wei; Shasha Geng; Chengzhi He; Hua Jiang
Journal:  Am J Cancer Res       Date:  2015-03-15       Impact factor: 6.166

4.  SMAD4 loss limits the vulnerability of pancreatic cancer cells to complex I inhibition via promotion of mitophagy.

Authors:  Zuzana Ezrova; Zuzana Nahacka; Jan Stursa; Lukas Werner; Erik Vlcak; Petra Kralova Viziova; Michael V Berridge; Radislav Sedlacek; Renata Zobalova; Jakub Rohlena; Stepana Boukalova; Jiri Neuzil
Journal:  Oncogene       Date:  2021-03-08       Impact factor: 9.867

5.  Targeting Tumor Metabolism With Statins During Treatment for Advanced-stage Pancreatic Cancer.

Authors:  Nick A Iarrobino; Beant Gill; Mark E Bernard; Mark V Mishra; Colin E Champ
Journal:  Am J Clin Oncol       Date:  2018-11       Impact factor: 2.339

Review 6.  Harnessing the Immune System in Pancreatic Cancer.

Authors:  Satya Das; Jordan Berlin; Dana Cardin
Journal:  Curr Treat Options Oncol       Date:  2018-08-20

Review 7.  From somatic mutation to early detection: insights from molecular characterization of pancreatic cancer precursor lesions.

Authors:  Catherine G Fischer; Laura D Wood
Journal:  J Pathol       Date:  2018-12       Impact factor: 7.996

8.  Curcumin inhibits the proliferation and invasion of human osteosarcoma cell line MG-63 by regulating miR-138.

Authors:  Dazhi Yu; Fengmei An; Xu He; Xuecheng Cao
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

9.  INPP4B As A Prognostic And Diagnostic Marker Regulates Cell Growth Of Pancreatic Cancer Via Activating AKT.

Authors:  Shuyu Zhai; Yuanbin Liu; Xiongxiong Lu; Hao Qian; Xiaomei Tang; Xi Cheng; Yue Wang; Yusheng Shi; Xiaxing Deng
Journal:  Onco Targets Ther       Date:  2019-10-09       Impact factor: 4.147

10.  MiR-130a-3p regulates cell migration and invasion via inhibition of Smad4 in gemcitabine resistant hepatoma cells.

Authors:  Yang Liu; Yumei Li; Rui Wang; Shukui Qin; Jing Liu; Fang Su; Yan Yang; Fuyou Zhao; Zishu Wang; Qiong Wu
Journal:  J Exp Clin Cancer Res       Date:  2016-01-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.